Educational Program for Preeclampsia
(PrEPS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new app designed to assist people with preeclampsia, a complication affecting about 8% of pregnancies. The goal is to determine if this illustration-based app improves understanding of the condition more effectively than traditional text-based instructions. Participants will use either the illustration-based or text-based application to learn about the risks, symptoms, and warning signs of preeclampsia. The trial suits those who have preeclampsia, can read and speak English, and have regular access to a mobile device. As an unphased trial, it offers a unique opportunity to contribute to innovative educational tools that could enhance patient understanding and management of preeclampsia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this educational program is safe for patients?
Research has shown that educational tools, such as apps, are generally safe. No evidence suggests that using an app with illustrations to learn about preeclampsia causes harm.
Both the illustration-based app and the text-based app in this trial aim to provide information. They do not involve drugs or medical procedures, which typically carry a higher risk of side effects. Since this trial focuses on education, it lacks the physical safety risks often associated with drug trials.
In summary, using an app to learn about preeclampsia is considered safe. The goal is to enhance understanding, which can aid in early risk detection.12345Why are researchers excited about this trial?
Researchers are excited about this educational program for preeclampsia because it aims to enhance patient understanding through innovative delivery methods. Unlike traditional approaches that often rely on in-person counseling or printed materials, this program uses digital applications—one based on illustrations and another on text—making it more accessible and engaging. The illustration-based application is particularly unique, as it leverages visual learning to convey complex medical information, which could be more effective for certain learners. By utilizing these modern digital tools, the program has the potential to improve patient awareness and management of preeclampsia, leading to better health outcomes.
What evidence suggests that this trial's educational programs could be effective for preeclampsia?
This trial will compare two educational approaches for preeclampsia: an illustration-based application and a text-based application. Studies have shown that mobile apps can significantly enhance pregnant women's knowledge about preeclampsia, including understanding the condition, recognizing risk factors, and identifying warning signs. Research also indicates that these educational tools improve women's understanding of heart health risks related to preeclampsia. By employing engaging and interactive formats, such as illustrations, these programs aim to provide women with crucial health information. Early findings suggest that this approach can lead to better health outcomes by promoting informed decision-making and self-care during pregnancy.16789
Who Is on the Research Team?
Megan Oakes, MD MSCI
Principal Investigator
Magella Medical Group, MemorialCare
Are You a Good Fit for This Trial?
This trial is for pregnant individuals diagnosed with preeclampsia who can read and speak English, receive care from specific clinics, and have consistent access to a mobile device that can scan QR codes and run applications.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive education via either an illustration-based app or a text-based app
Short-term Follow-up
Participants' preeclampsia knowledge scores are assessed 24 hours post-intervention
Long-term Follow-up
Participants' preeclampsia knowledge scores and other secondary outcomes are assessed between 4 to 6 weeks postpartum
What Are the Treatments Tested in This Trial?
Interventions
- Illustration based application
- Text based application
Find a Clinic Near You
Who Is Running the Clinical Trial?
MemorialCare Health System
Lead Sponsor